Cerimon Pharmaceuticals
Cerimon Pharmaceuticals develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Cerimon Pharmaceuticals Information
Geographic Data
Address:
City: South San Francisco
State: California
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$233k
Raised Total:$73M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cerimon Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for autoimmune diseases, inflammation, and pains in the United States and Europe. It develops Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, including pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. Cerimon Pharmaceuticals, Inc. was founded in 2004 and is headquartered in South San Francisco, California.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2009 | Series A | $1.5M | 11/2010 | Series A | $233k | 6/2010 | Series A | $1M | 10/2005 | Series A | 3 | $70M |
MPM Capital OrbiMed Phase4 Ventures MPM Capital OrbiMed Phase4 Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
